Preimplantation Genetic Testing

  • Home
  • Preimplantation Genetic Testing

Preimplantation Genetic Testing refers to the removal of a few cells from an embryo at the blastocyst stage to test for chromosomal normality. It checks the embryo for normal chromosome number as well as other issues. We believe in using the most advanced technology of NGS (Next Generation Sequencing). In simple words this technology is highly reliable for detecting abnormal and semi-normal or mosaic embryos.

There are three different types of tests performed in PGT:

  • Preimplantation genetic screening for abnormal chromosome number (PGT-A)
  • Preimplantation genetic testing for monogenic (single gene disorders) disease (PGT-M)
  • Preimplantation genetic testing structural rearrangement (PGT-SR) for known chromosomal misarrangements such as inversion and translocation.

Who Should Opt for Preimplantation Genetic Testing:

  1. Couples with a history of genetic disorders.

  2. Women of advanced maternal age (typically 35+).

  3. Couples with recurrent pregnancy loss or miscarriage.

  4. Individuals with repeated IVF failure.

  5. Carriers of chromosomal abnormalities (e.g., translocations).


Benefits of Preimplantation Genetic Testing:

  1. Identifies genetic or chromosomal abnormalities before embryo transfer.

  2. Increases chances of a healthy pregnancy and baby.

  3. Reduces risk of miscarriage due to genetic issues.

  4. Helps select the most viable embryos for implantation.

  5. Supports informed decision-making for parents at genetic risk.